Newsletters

PBI is active in the community, providing educational information to patients and their families on living with a blood disorder. Additionally, we regularly hold events for both health professionals and members of the community.

We are pleased to outline exciting developments at PBI through regular and diverse communications with our stakeholders.

Read our latest news

Archived issues of Blood Matters newsletters are available to download:

We now send news and event updates quarterly by email. Please subscribe below.

Latest

Research Team Awarded DARF Dementia Grant

Perth Blood Institute is pleased to announce it is the recipient of the Norma Beaconsfield Project Grant, awarded by the Dementia Australia Research Foundation (DARF). This grant will allow the Platelet Research Team to continue important investigations into the effect of blood-thinning medication on dementia risk.
Covid-19 - Impact on blood transfusions and blood donations

Some members of the community may be concerned about the potential transmission of the COVID-19 virus through blood products, such as through blood transfusions. If you rely on blood products, you should feel confident to continue to receive them.
COVID-19

Perth Blood Institute takes the health of our staff, patients and supporters very seriously. We are responding to the COVID-19 situation and reviewing our protocols and responses daily. We thank all our stakeholders for working with us at this time. Cate Cassarchis, CEO
Investigating the effects of chronic Factor X anticoagulant exposure and dementia risk

This project aims to examine FXa inhibition on the risk of cognitive decline and investigates the molecular mechanisms underlying this association.

Accessibility
Research Team Awarded DARF Dementia Grant

Perth Blood Institute is pleased to announce it is the recipient of the Norma Beaconsfield Project Grant, awarded by the Dementia Australia Research Foundation (DARF). This grant will allow the Platelet Research Team to continue important investigations into the effect of blood-thinning medication on dementia risk.
Privacy Policy

THE PERTH BLOOD INSTITUTE LIMITED ABN: 24164941815 (trading as Perth Blood Institute) takes your privacy seriously. We respect and uphold your right to privacy protection under the Australian Privacy Principles (APPs), by regulating the way in which we collect, use, disclose, hold and destroy your personal information. This Privacy Policy covers all personal information held by us.
Terms and Conditions
Covid-19 - Impact on blood transfusions and blood donations

Some members of the community may be concerned about the potential transmission of the COVID-19 virus through blood products, such as through blood transfusions. If you rely on blood products, you should feel confident to continue to receive them.
Perth Blood Institute

Your donation can help PBI to fund vital translational research into blood disorders including thrombosis and haemophilia; support a clinical research investigation into the development of a new treatment or intervention; or help us develop educational programs to foster the next generation of career haematologists.
Make a bequest
Pancreatic Cancer study published

Pancreatic cancer is one of the deadliest diseases. A recent study led by PBI Scientist Dr Omar Elaskalani has been published in a special issue of Cancers by MDPI, a peer-reviewed academic journal. The study offers promising evidence that a commonly used blood thinner may help pancreatic cancer patients.
COVID-19 Updates

Perth Blood Institute takes the health of our staff, patients and supporters very seriously. We are responding to the COVID-19 situation and reviewing our protocols and responses daily. We thank all our stakeholders for working with us at this time. Cate Cassarchis, CEO
Cockcroft-Gault Equation

Follow this link to find information regarding the Cockcroft-Gault equation.

Perth Blood Institute

Your donation can help PBI to fund vital translational research into blood disorders including thrombosis and haemophilia; support a clinical research investigation into the development of a new treatment or intervention; or help us develop educational programs to foster the next generation of career haematologists. Read more

Donate Fundraise